Back to Search
NEIL CLENDENINN, MD
MD
Hospice and Palliative Medicine (Internal Medicine) Physician
NPI: 1972840759Individual
Specialties, Licenses & Credentials
Hospice and Palliative Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
13184(HI)
Research & Publications (7)
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma.
PMID 16957834·Invest New Drugs·2007
3-trial
Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor.
PMID 14871966·Clin Cancer Res·2004
3-trial
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.
PMID 11822760·Ann Oncol·2001
3-trial
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).
PMID 11600825·AIDS·2001
3-trial
Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapy.
PMID 11302807·Antimicrob Agents Chemother·2001
8-other
A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation.
PMID 11139306·Br J Cancer·2001
3-trial
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks.
PMID 10803927·Cancer Chemother Pharmacol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4335 ANINI VISTA DRIVE
PRINCEVILLE, HI 96722 - Phone
- (808) 294-0660
Quick Facts
- NPI
- 1972840759
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile